Beginning Oct. 1, CMS will provide hospitals with additional device reimbursement when a single-use duodenoscope is used for eligible cases of endoscopic retrograde cholangiopancreatography procedures in the hospital inpatient setting.
The add-on is applicable to Boston Scientific’s Exalt Model D Single-Use Duodenoscope, a device designed to eliminate infections caused by ineffective reprocessing of reusable duodenoscopes.
The Exalt Model D Single-Use Duodenoscope was granted transitional pass-through payment by CMS in 2020, allowing for incremental device reimbursement for cases performed in the hospital outpatient setting.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
